The Board of Directors of iX Biopharma Ltd. announced the following changes with effect from 27 October 2021: Mr. Patrick Donald Davies be appointed as the Chairperson of the Nominating Committee and a member of Risk Management Committee; and Mr. Albert Ho Shing Tung be appointed as the Chairperson of the Risk Management Committee. Mr. Patrick Donald Davies was appointed to the Board as an Independent Director on 2 December 2019 and serves as the Chairperson of the Remuneration Committee and a member of the Audit and Nominating Committees. Mr. Albert Ho Shing Tung was appointed to the Board as a Non-Executive Non-Independent Director on 1 March 2013 and serves as a member of the Audit, Remuneration and Risk Management Committees.